<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>automated alerts &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/automated-alerts/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 26 Oct 2026 23:28:30 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>automated alerts &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>WeChat-Based Platform Shows Moderate Usability for Managing Chemotherapy-Induced Myelosuppression in Breast Cancer</title>
		<link>https://bioengineer.org/wechat-based-platform-shows-moderate-usability-for-managing-chemotherapy-induced-myelosuppression-in-breast-cancer/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Mon, 26 Oct 2026 23:28:30 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[automated alerts]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[chemotherapy-induced myelosuppression]]></category>
		<category><![CDATA[complete blood count]]></category>
		<category><![CDATA[health informatics]]></category>
		<category><![CDATA[mHealth]]></category>
		<category><![CDATA[mobile health]]></category>
		<category><![CDATA[patient self-management]]></category>
		<category><![CDATA[Pilot Study]]></category>
		<category><![CDATA[remote monitoring]]></category>
		<category><![CDATA[User-Centered Design]]></category>
		<category><![CDATA[WeChat]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=458082</guid>

					<description><![CDATA[A user-centered study from Zunyi Medical University reports that a WeChat-embedded platform for monitoring chemotherapy-induced myelosuppression in breast cancer patients achieved moderate usability in an eight-patient pilot, with its automated alert system correctly grading all abnormal blood count results against WHO criteria.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">458082</post-id>	</item>
	</channel>
</rss>
